Skip to content

About Us
Technology
Pipeline
- Overview
- D-4517.2
- OP-801
- OP-101
News
Resources
Careers
Contact

About Us
Technology
Pipeline
- Overview
- D-4517.2
- OP-801
- OP-101
News
Resources
Careers
Contact

Resource Type: Media

Scrip Asks…What Does 2023 Hold For Biopharma? Part 8: Therapeutic Area Advances

First patient enrolled in phase 1/2 study of hydroxyl dendrimer imaging agent

Economic Forecast 2023: New challenges in biotech’s ‘valley of death’

Biospace Movers & Shakers: Maravai, Predictive Oncology, Exagen and More Tap New Execs

Enrollment underway in phase 2 study of subcutaneous anti-VEGF wet AMD, DME candidate

Ashvattha previews plans for long Covid trial in mid-2023

Clinical Trials Arena

Ashvattha’s OP-101 boosts clinical outcomes in Phase IIa Covid-19 trial

Clinical Trials Arena

Getting Across Tissue Barriers for Precise Delivery of Drugs with Jeff Cleland Ashvattha Therapeutics

Empowered Patient Podcast

In which orphan spaces or unmet medical needs do you think we will see the next treatment innovations?

Pharma’s almanac

What do you consider the biggest challenge that the pharma/biopharma industry currently faces?

Pharma’s almanac

Older posts

Page1 Page2 Next →

Search for:

Recent Posts

Ashvattha Therapeutics to Participate in Upcoming Ophthalmology Conferences
Ashvattha Therapeutics Announces First Patient Dosed via Subcutaneous Administration of Anti-Angiogenic Therapeutic D-4517.2 for Wet AMD and DME in Phase 2 Chronic Dosing Study
Ashvattha Therapeutics Announces Appointment of Dr. Sakura Minami as Vice President of Translational Medicine and Nonclinical Development and Sarah Thayer as Head of Clinical Operations
Ashvattha Therapeutics Presents Promising Preclinical Data on New Dendranib Nanomedicine Candidate ASH41020 at the 16th International Society of Neuroimmunology Congress (ISNI)
Ashvattha Therapeutics Announces Poster Presentation of Preclinical Data on New ‘Dendranib’ Nanomedicine Candidate at the 16th International Society of Neuroimmunology Congress (ISNI)

Recent Comments

Archives

November 2023
October 2023
August 2023
May 2023
April 2023
February 2023
January 2023
October 2022
September 2022
August 2022
July 2022
June 2022
May 2022
April 2022
September 2021
June 2021
May 2021
April 2021
December 2020
November 2020
October 2020
September 2020
August 2020
June 2020
May 2020

Categories

In the News
Press Release

Meta

Log in
Entries feed
Comments feed
WordPress.org

Howdy, this is Creativo

We just added a brand new Off Canvas Sidebar. You can change the content you see here by going to Appearance -> Widgets -> Off Canvas Sidebar.

Of course you can also change the design of this sidebar by going to Appearance -> Theme Options -> Off Canvas Sidebar.

Change everything from: background color, font color, font size, sidebar headings and more.

© Copyright 2023 Ashvattha Therapeutics.

Privacy Policy

© 2023 Ashvattha Therapeutics • Built with GeneratePress